The role of oxidative stress in chronic kidney disease

Seminars in Dialysis

Volumn 22, Issue 4, 2009, Pages 405-408

  Massy, Ziad A ^a,d   Stenvinkel, Peter ^b   Drueke, Tilman B ^c  

^a UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c INSERM   (France)

^d AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; KIDNEY DISEASE; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY;

HUMANS; KIDNEY DISEASES; OXIDATIVE STRESS;

EID: 69249098847     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2009.00590.x     Document Type: Article

References (45)

1. Nguyen-Khoa T, Massy ZA, Witko-Sarsat V, Canteloup S, Kebede M, Lacour B, Drueke T, Descamps-Latscha B : Oxidized low-density lipoprotein induces macrophage respiratory burst via its protein moiety: a novel pathway in atherogenesis? Biochem Biophys Res Commun, 263 : 804 809, 1999
2. Nguyen-Khoa T, Massy ZA, De Bandt JP, Kebede M, Salama L, Lambrey G, Witko-Sarsat V, Drueke TB, Lacour B, Thevenin M : Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant, 16 : 335 340, 2001
3. Handelman GJ, Walter MF, Adhikarla R, Gross J, Dallal GE, Levin NW, Blumberg JB : Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney Int, 59 : 1960 1966, 2001
4. Holvoet P, Donck J, Landeloos M, Brouwers E, Luijtens K, Arnout J, Lesaffre E, Vanrenterghem Y, Collen D : Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure. Thromb Haemost, 76 : 663 669, 1996
5. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B : Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int, 49 : 1304 1313, 1996
6. Satoh M, Yamasaki Y, Nagake Y, Kasahara J, Hashimoto M, Nakanishi N, Makino H : Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters. Kidney Int 59 : 1943 1950, 2001
7. Malle E, Woenckhaus C, Waeg G, Esterbauer H, Grone EF, Grone HJ : Immunological evidence for hypochlorite-modified proteins in human kidney. Am J Pathol, 150 : 603 615, 1997
8. Sakata N, Imanaga Y, Meng J, Tachikawa Y, Takebayashi S, Nagai R, Horiuchi S : Increased advanced glycation end products in atherosclerotic lesions of patients with end-stage renal disease. Atherosclerosis, 142 : 67 77, 1999
9. Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA, Himmelfarb J : Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int, 65 : 1009 1016, 2004
10. Pupim LB, Himmelfarb J, McMonagle E, Shyr Y, Ikizler TA : Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stress. Kidney Int 65 : 2371 2379, 2004
11. Miyata T, Sugiyama S, Saito A, Kurokawa K : Reactive carbonyl compounds related uremic toxicity ("carbonyl stress"). Kidney Int 78 (Suppl S25 S31, 2001
12. Massy ZA, Ceballos I, Chadefaux-Vekemens B, Nguyen-Khoa T, Descamps-Latscha B, Drueke TB, Jungers P : Homocyst(e)ine, oxidative stress, and endothelium function in uremic patients. Kidney Int 78 (Suppl S243 S245, 2001
13. Nguyen AT, Lethias C, Zingraff J, Herbelin A, Naret C, Descamps-Latscha B : Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood. Kidney Int 28 : 158 167, 1985
14. Drueke TB, Massy ZA : Intravenous iron: how much is too much? J Am Soc Nephrol 16 : 2833 2835, 2005
15. Sela S, Shurtz-Swirski R, Cohen-Mazor M, Mazor R, Chezar J, Shapiro G, Hassan K, Shkolnik G, Geron R, Kristal B : Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. J Am Soc Nephrol 16 : 2431 2438, 2005
16. Ramos LF, Shintani A, Ikizler TA, Himmelfarb J : Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. J Am Soc Nephrol 19 : 593 599, 2008
17. Roselaar SE, Nazhat NB, Winyard PG, Jones P, Cunningham J, Blake DR : Detection of oxidants in uremic plasma by electron spin resonance spectroscopy. Kidney Int 48 : 199 206, 1995
18. Nagase S, Aoyagi K, Hirayama A, Gotoh M, Ueda A, Tomida C, Kamezaki T, Nagai Y, Kikuchi H, Koyama A : Favorable effect of hemodialysis on decreased serum antioxidant activity in hemodialysis patients demonstrated by electron spin resonance. J Am Soc Nephrol 8 : 1157 1163, 1997
19. Dantoine TF, Debord J, Charmes JP, Merle L, Marquet P, Lachatre G, Leroux-Robert C : Decrease of serum paraoxonase activity in chronic renal failure. J Am Soc Nephrol 9 : 2082 2088, 1998
20. Moh A, Sakata N, Takebayashi S, Tateishi K, Nagai R, Horiuchi S, Chihara J : Increased production of urea hydrogen peroxide from Maillard reaction and a UHP-Fenton pathway related to glycoxidation damage in chronic renal failure. J Am Soc Nephrol 15 : 1077 1085, 2004
21. Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimburger O, Massy Z : Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 3 : 505 521, 2008
22. Massy ZA, Borderie D, Nguyen-Khoa T, Drueke TB, Ekindjian OG, Lacour B : Increased plasma S-nitrosothiol levels in chronic haemodialysis patients. Nephrol Dial Transplant 18 : 153 157, 2003 (Pubitemid 36104492)
23. Himmelfarb J, McMenamin ME, Loseto G, Heinecke JW : Myeloperoxidase- catalyzed 3-chlorotyrosine formation in dialysis patients. Free Radic Biol Med 31 : 1163 1169, 2001
24. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T : Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55 : 1899 1911, 1999 (Pubitemid 29197978)
25. Boaz M, Matas Z, Biro A, Katzir Z, Green M, Fainaru M, Smetana S : Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis. Kidney Int 56 : 1078 1083, 1999
26. Bolton CH, Downs LG, Victory JG, Dwight JF, Tomson CR, Mackness MI, Pinkney JH : Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant 16 : 1189 1197, 2001
27. Bayes B, Pastor MC, Bonal J, Junca J, Hernandez JM, Riutort N, Foraster A, Romero R : Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients. Nephrol Dial Transplant 18 : 106 112, 2003
28. Descamps-Latscha B, Witko-Sarsat V, Nguyen-Khoa T, Nguyen AT, Gausson V, Mothu N, London GM, Jungers P : Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients. Am J Kidney Dis 45 : 39 47, 2005
29. Stenvinkel P, Diczfalusy U, Lindholm B, Heimburger O : Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy. Nephrol Dial Transplant 19 : 972 976, 2004
30. Faggiotto A, Poli A, Catapano AL : Antioxidants and coronary artery disease. Curr Opin Lipidol 9 : 541 549, 1998
31. Suliman ME, Heimburger O, Barany P, Anderstam B, Pecoits-Filho R, Rodriguez Ayala E, Qureshi AR, Fehrman-Ekholm I, Lindholm B, Stenvinkel P : Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy. J Am Soc Nephrol 14 : 1614 1622, 2003
32. Schwedler S, Schinzel R, Vaith P, Wanner C : Inflammation and advanced glycation end products in uremia: simple coexistence, potentiation or causal relationship? Kidney Int 78 (Suppl S32 S36, 2001
33. Ivanovski O, Szumilak D, Nguyen-Khoa T, Ruellan N, Phan O, Lacour B, Descamps-Latscha B, Drueke TB, Massy ZA : The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice. Kidney Int 67 : 2288 2294, 2005
34. Phan O, Ivanovski O, Nguyen-Khoa T, Mothu N, Angulo J, Westenfeld R, Ketteler M, Meert N, Maizel J, Nikolov IG, Vanholder R, Lacour B, Drueke TB, Massy ZA : Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice. Circulation 112 : 2875 2882, 2005 (Pubitemid 41641683)
35. Amann K, Tornig J, Buzello M, Kuhlmann A, Gross ML, Adamczak M, Ritz E : Effect of antioxidant therapy with dl-alpha-tocopherol on cardiovascular structure in experimental renal failure. Kidney Int 62 : 877 884, 2002
36. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS : Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 356 : 1213 1218, 2000
37. Himmelfarb J, Kane J, McMonagle E, Zaltas E, Bobzin S, Boddupalli S, Phinney S, Miller G : Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease. Kidney Int 64 : 978 991, 2003
38. Tarng DC, Huang TP, Liu TY, Chen HW, Sung YJ, Wei YH : Effect of vitamin E-bonded membrane on the 8-hydroxy 2′-deoxyguanosine level in leukocyte DNA of hemodialysis patients. Kidney Int 58 : 790 799, 2000
39. Miyazaki H, Matsuoka H, Itabe H, Usui M, Ueda S, Okuda S, Imaizumi T : Hemodialysis impairs endothelial function via oxidative stress: effects of vitamin E-coated dialyzer. Circulation, 101 : 1002 1006, 2000
40. Morimoto H, Nakao K, Fukuoka K, Sarai A, Yano A, Kihara T, Fukuda S, Wada J, Makino H : Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients. Nephrol Dial Transplant 20 : 2775 2782, 2005
41. Morena M, Gausson V, Mothu N, Bouchet JL, Chanas M, Grandvuillemin M, Robert A, Vela C, Canaud B, Cristol JP, Olmer M : Regional variations of low-density lipoprotein oxidizability in hemodialysis patients may explain discrepancies in interventional therapy on oxidative profile. Blood Purif 26 : 300 310, 2008
42. Tepel M, van der Giet M, Statz M, Jankowski J, Zidek W : The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial. Circulation 107 : 992 995, 2003
43. Witko-Sarsat V, Gausson V, Nguyen AT, Touam M, Drueke T, Santangelo F, Descamps-Latscha B : AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients. Kidney Int 64 : 82 91, 2003
44. Nolin TD, McMenamin ME, Himmelfarb J : Simultaneous determination of total homocysteine, cysteine, cysteinylglycine, and glutathione in human plasma by high-performance liquid chromatography: application to studies of oxidative stress. J Chromatogr B Analyt Technol Biomed Life Sci 852 : 554 561, 2007
45. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E : Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353 : 238 248, 2005 (Pubitemid 41058323)